Skip to main content
https://pbs.twimg.com/media/GGZmqdobQAYyLuX.jpg
Combo IL-23 and TNFi synergistic benefit in UC in the proof-of-concept VEGA trial. More data to come! #RWCS24 @RWCSmtg @RheumNow https://t.co/FgLTR2PBYJ
Dr. Rachel Tate
Feb-16-2024
×